CAMBRIDGE, MA, Solarea Bio,announced first closing of $15M in Series B financing.
Solarea Bio, a clinical stage biotechnology company based in Cambridge, MA developing food-derived microbial-based solutions to aid human health, announced a first closing of $15M in a Series B financing led by S2G Ventures with continued participation of Bold Capital Partners,
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
